key: cord-0771788-nfrv0abt
authors: Nakagama, Y.; Rodriguez-Funes, M.-V.; Dominguez, R.; Candray-Medina, K.-S.; Uemura, N.; Tshibangu-Kabamba, E.; Nitahara, Y.; Kaku, N.; Kaneko, A.; Kido, Y.
title: Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America.
date: 2022-02-07
journal: nan
DOI: 10.1101/2022.02.06.22270565
sha: 939fdd792235bfbb494fe1434dcc68e83e269884
doc_id: 771788
cord_uid: nfrv0abt

Background The impact of novel coronavirus disease 2019 (COVID-19) on healthcare workers (HCWs) has been under-evaluated in Central America. We performed a seroepidemiological survey at a tertiary healthcare facility in El Salvador, where a large number of confirmed and far more suspected cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected HCWs had been documented during the first wave of the pandemic. Methods During January-February 2021, a total 973 HCWs were tested for SARS-CoV-2 antibodies. Participants completed a questionnaire asking of their demographic data. Occupational risk was assessed by statistically comparing the seropositivity rates among different occupational categories. Results Overall seroprevalence in HCWs reached 52.6% (512 of 973). Of the seropositive individuals, 61.7% (316 of 512) had experienced a documented COVID-19 diagnosis, while the remaining 38.3% (196 of 512) were unrecognized seroconversions. Differences in seropositivity rates existed between occupational categories; nurses demonstrated the highest at 63.8% (222 of 348, risk ratio 1.44, p < 0.0001), followed by auxiliary HCWs assigned to patient-related work (55.9%, 52 of 93), and medical doctors (46.7%, 50 of 107). Several non-patient-related professions showed above-average seroprevalence, suggesting substantial SARS-CoV-2 contacts outside the workplace: 60.0% (6 of 10) and 68.0% (17 of 25) for nutritionists and pharmacists, respectively. Conclusions SARS-CoV-2 seroprevalence exceeded 50% among HCWs in El Salvador, with disparity among occupational categories with different workplace exposure risks. Importance of not only nosocomial infection prevention but also screening for transmissions having occurred outside the workplace were highlighted to efficiently control nosocomial spreads during a pandemic wave.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint 4 assigned to patient-related work (55.9%, 52 of 93), and medical doctors (46.7%, 50 of 107).

Several non-patient-related professions showed above-average seroprevalence, suggesting substantial SARS-CoV-2 contacts outside the workplace: 60.0% (6 of 10) and 68.0% (17 of 25) for nutritionists and pharmacists, respectively.

Conclusions SARS-CoV-2 seroprevalence exceeded 50% among HCWs in El Salvador, with disparity among occupational categories with different workplace exposure risks. Importance of not only nosocomial infection prevention but also screening for transmissions having occurred outside the workplace were highlighted to efficiently control nosocomial spreads during a pandemic wave. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The novel coronavirus disease 2019 (COVID-19) pandemic has threatened the public health systems worldwide. Its impact, however, has been under-evaluated in most lowand middle-income countries, due to their lacking access to testing modalities. Central America is among the regions which utmost suffer scarcity of seroepidemiological data [1, 2] .

Under such circumstances, El Salvador reports a cumulative incidence rate at 1900 cases per 100,000 population by January 2022, ranking among the lowest in the Central Americas, only second to Nicaragua, where the government had officially set testing restrictions [3] .

However, considering the limited testing capacity for active case detection, as well as further results from prior research reporting of excessive unrecognized seroconversions [4, 5] , substantial underestimation of the burden is anticipated.

Healthcare workers (HCWs) encounter the SARS-CoV-2 virus at the frontline and are representative of the highest risk individuals. Large healthcare-associated outbreaks not only endanger the assurance of quality care in the midst of a pandemic, but also may impact the kinetics of spread within the society [6] . We herein launched a seroepidemiological survey, extending from end-January to mid-February 2021, at a tertiary care referral hospital located in the capital city of El Salvador, where a large number of confirmed and far more suspected is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint cases of SARS-CoV-2 affected HCWs had been documented during the first wave of the pandemic.

A total 1144 HCWs from the National Clinical Laboratory and the National Rosales Hospital, El Salvador, were recruited to participate. The sites were the main referral facilities in the capital city of San Salvador for COVID-19 at the beginning of the pandemic from May to July 2020, having 116 beds across six wards constantly filled with patients of various severity.

Strict measures were taken so that HCWs having been dedicated to work related to COVID-19 patients were isolated from the rest. Upon recruitment, the participants completed a questionnaire asking for their demographic data, anthropometric measurements, past medical history, occupational role, and clinical information related to any prior COVID-19 diagnosis given to the participant. Such clinical information included the mode of COVID-19 diagnosis (either laboratory-confirmed by polymerase chain reaction (PCR) based testing, or lacking a definitive laboratory test but clinically determined), self-reported signs/symptoms related with COVID-19, as well as their severity, and day of onset, if documented.

Occupational roles were further divided into four categories: (i) medical doctors, (ii) nurses, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint (iii) other patient-related: those including the subcategories of respiratory care specialist, radiology personnel, cleaning staff, and other auxiliary HCWs who come into close contact with patients, such as transportation or security personnel, and (iv) non-patient-related: those who basically work aside from patients, including the subcategories of blood bank personnel, laboratory professional, administrative officer, nutritionist, and pharmacist. The presence/absence of a participants' family member at his/her home with a COVID-19 diagnosis was queried to gain insight into the degrees of household contact/transmission. A total 973 subjects (973 of 1144, 85%), who consented to have their serum drawn and sent to Japan for evaluation, were eligible for the analysis (Figure) . Sera were collected during a 3weeks period (from end-January to mid-February 2021), aliquoted under sterile conditions, stored at -80ºC, and shipped to Osaka City University, Osaka, Japan, where the serological analyses were performed.

Analyses were conducted in accordance with the ethical standards noted in the 1964 Declaration of Helsinki and its later amendments. The research was approved by the Osaka City University Institutional Ethics Committee (#2020-003) and the National Research Ethics Committee of El Salvador (#CNEIS/2020/029). Consent for participation and publication was . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. 'indeterminate', if discordant in the two immunoassay results. We have adopted similar orthogonal case detection approaches to successfully detect COVID-19 convalescent individuals with excellent sensitivity/specificity: 100% (95% CI, 68-100%) and 100% (95% CI, 94-100%), respectively [4, 5] .

. CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint 9

The results of serological testing were described as frequencies and percentages among the participants screened. Univariate analysis was performed to identify the variables associated with seropositivity. Comparisons of variables were made between 'seronegative' and 'seropositive' individuals. For the between-category comparison of seropositivity rate and the frequency of having a COVID-19 family member in the household, the 'non-patient-related' occupational category served as the reference group. Chi-square test was used for categorical comparisons of data. Mann-Whitney's test was used to compare differences among continuous variables. Tests were two-sided, and a threshold of 0.05, or, for the multiple comparisons made between different occupational categories when assessing the differences in seropositivity rate and frequency of household contact, the Bonferroni-adjusted threshold of 0.017, was used to determine statistically significant p-values. Statistical analysis and artwork preparation were done using the GraphPad Prism software.

A total 973 participants, aged 43 ± 11 years (mean ± SD), were enrolled (Figure, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint of 973) assigned to other patient-related work, and 43.7% (425 of 973) assigned to nonpatient-related work. 25.3% (246 of 973) reported of having at least one high-risk chronic comorbidity, such as diabetes, hypertension, ischemic heart disease, cerebrovascular disease, cancer, and/or chronic obstructive pulmonary disease. Participants were 33.3%

(324 of 973) obese, reporting a body mass index (BMI) of 30 or higher ( Table 1) .

The orthogonal testing algorithm revealed an overall seropositivity rate of 52.6% is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. 

In the further analysis, those with discordant serological testing results were excluded, and comparisons were made between 'seropositive' and 'seronegative' individuals to assess for factors related with seropositivity. Neither age in years (43 ± 11 vs 44 ± 12, p = 0.10) nor sex (male sex: 27.3% vs 29.5%, p = 0.46) were associated with serological status (seropositive vs seronegative, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint towards lower seroprevalence compared with HCWs commuting from the other 13 departments of the country (50.4% vs 57.5%, p = 0.059), but the difference did not reach statistical significance.

Risk for seropositivity was next compared between different occupational categories ( Table 2) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint

The rate of reporting any family member with a COVID-19 diagnosis was almost uniform among occupational categories (Table 3) . Such negligible variety in household contact rates was seemingly insufficient to explain the observed significant disparity in seropositivity rate among occupational categories.

This is the first and only study to date, presenting data on SARS-CoV-2 seroprevalence in Salvadorian HCWs. In three independent meta-analysis studies, the overall seroprevalence of SARS-CoV-2 antibodies among HCWs was estimated to range globally from 8.0% to 8.7% [8] [9] [10] . One of the studies further described the regional differences in pooled serological prevalence of SARS-CoV-2 IgG antibodies; a higher seropositivity rate was observed in the USA (12.4%, 95% confidence interval (CI) = 7.8-17%) than in Europe (7.7%, 95% CI=6.3-9.2%) and East Asia (4.8%, 95% CI=2.9-6.7%) [8] is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint (196 of 512) was unveiled among the total seropositive individuals. According to the epidemiological updates released by the Pan American Health Organization, the expected cumulative cases, as well as deaths, due to COVID-19 among HCWs in El Salvador had totaled to 6,609 cases and 71 deaths up until 8 February 2021, the date that approximates the period of conduct of our study [11] . Owing to the strengthening of the healthcare facilities' preparedness, the rise of these numbers from El Salvador, as well as the entire Central Americas, have seemingly been curbed during the following months [12] . The significant number of unrecognized seroconversions revealed in the present study, however, highlights the possibility of these estimates being under-representative of the true burden.

The unique feature of the presented cohort was the discrepancy among occupational category in the risk of contracting the disease. Nurses, coming most frequently into direct and closest contact with COVID-19 patients, had significantly increased rates of seropositivity, compared with auxiliary non-patient-related HCWs. Conversely, risk differences were less evident between occupational categories in the studies targeting HCWs from Belgium, the United Kingdom or USA [13] [14] [15] . Taken together, the interpretation of occupational risk of workplace exposure imposed to frontline HCWs seems highly dependent on context such as national circumstances. The observed occupation-specific relative risks, that differ from report to report, are likely to reflect their local situations of practice, including is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint 15 access, as well as adherence to protective measures within the healthcare facility. The higher risk in the more near-patient HCWs shown in the presented cohort suggests that, despite strict protective measures set out for infection control, workplace transmission has persistently contributed to the spread of SARS-CoV-2 among Salvadorian HCWs. This may be attributable, at least in part, to the continuous shortage in material or technical support on the HCWs' protective measures, which early on in the pandemic was a more universal situation [4, 6] . Interestingly, when occupation was further divided into subcategories, there existed heterogeneous trends in seropositivity rates within patient-related, as well as nonpatient-related professions. For example, respiratory care specialists in our HCW cohort, exclusively in charge of all tracheal intubation and extubation procedures of COVID-19 patients, carried less risk in contracting the disease compared with cleaning staff entering the COVID-19 ward. This apparently inverse relationship between aerosol exposure and seropositivity rate of the two subcategories, may have resulted from the differences in staffs' preparedness for personal protection and infection control. Prior to the present study, Nicaragua and Panama were the only countries to have ever reported on the impact of SARS-CoV-2 among their HCWs [16, 17] . Statistics on the mutual influence between the societal spread of SARS-CoV-2 and the healthcare systems' preparedness in the Central Americas remain further awaited. Our observation gives initial insight into SARS-CoV-2 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Our study has several limitations. Firstly, upon estimating the impact of the pandemic on HCWs, we here adopted a rather conservative approach on case definition that shall minimize false-positive errors. Although this approach has performed well in previous seroprevalence surveys with excellent sensitivity/specificity, considering every individual with discordant immunoassay results as 'seronegative' may have led to false-negative interpretations and underestimation of seroprevalence in a high-prevalence cohort as the present one. The seropositivity rate was derived from a single institution survey and thus may not represent the general HCW population of the country. Secondly, our discussions regarding the site of SARS-CoV-2 transmission among HCWs, whether workplace or community, remains elusive due to the following constraints. The community's seroprevalence data in El Salvador is still awaited in order to make direct comparisons with that of the HCWs. Transmission was also not directly monitored with molecular methods.

Finally, the questionnaire was designed so as to limit the target of some selected queries;

'presence/absence of COVID-19 symptoms' were queried to those with documented infections. Collecting answers to this specific query exhaustively from every participant could have given us better estimates to the frequency of asymptomatic COVID-19 infections within the cohort.

In conclusion, we discovered that SARS-CoV-2 seropositivity rate exceeded 50% is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Yasutoshi Kido also report receiving financial support outside of the work from Abbott Japan LLC, Japan. Tables   Table 1. Factors related with SARS-CoV-2 seropositivity.

a Chi-square test for categorical variables and Mann-Whitney's test for continuous variables. b Standard deviation. c Body mass index. d Statistically significant. e Indicates the rate of (seropositive or seronegative) / (total participants from specified location) in %. f One seropositive and one seronegative individual lacked a valid reply.

Total is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint

Covid-19 in Latin America

COVID-19 in Latin America

First report on prevalence of SARS-CoV-2 infection among health-care workers in Nicaragua

Serological testing reveals the hidden COVID-19 burden among health care workers experiencing a SARS-CoV-2 nosocomial outbreak

Prevalence of SARS-CoV-2-specific antibodies

Clusters of coronavirus disease in communities

COVID-19 -Information System for the Region of the Americas

Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis

Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers : a systematic review and metaanalysis

The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and metaanalysis

Pan American Health Organization. Epidemiological Update: Coronavirus disease (COVID-19

Pan American Health Organization. Epidemiological Update: Coronavirus disease (COVID-19) -27

Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment

Hospital-wide SARS-CoV-2 antibody screening in 3056

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

Vigilancia seroepidemiológica de la circulación del SARS-CoV-2 en 41 municipios de Honduras sin reporte de casos activos, COVID-19, del 16-23 junio 2020

Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and

The authors thank all healthcare workers who participated in the study as well as the coinvestigators that facilitated the data collection and the material transfer needed for completion of the study.

Yu Nakagama and Yasutoshi Kido report ownership of equity of Quantum Molecular is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 7, 2022. ;. CC-BY-NC 4.0 International license It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 7, 2022. ; https://doi.org/10.1101/2022.02.06.22270565 doi: medRxiv preprint